Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | PLD2 | O14939 | 1/20 | 0.31 |
| ▸ | PLD1 | Q13393 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8131373 | 0.76 | CYP1A2 (0.39) | CYP1A2PLD2PLD1KDM4EMEN1 | |
| SCHEMBL30640267 | 0.76 | CYP1A2 (0.39) | CYP1A2PLD2PLD1KDM4EMEN1 | |
| SCHEMBL461357 | 0.73 | HDAC8 (0.42) | CYP1A2PLD2PLD1SMN1; SMN2KDM4E | |
| SCHEMBL260496 | 0.69 | NOTUM (0.39) | HTTSMN1; SMN2MEN1CYP3A4MAPT | |
| Urea SCHEMBL6098803 | 0.68 | CYP1A2 (0.52) | CYP1A2KDM4EMEN1ALDH1A1CYP3A4 | |
| Urea SCHEMBL17710420 | 0.66 | CYP1A2 (0.50) | CYP1A2CYP3A4MAPTBLM | |
| Acetamide SCHEMBL28035592 | 0.64 | NOTUM (0.48) | CYP1A2ALDH1A1CYP3A4MAPTBLM | |
| SCHEMBL11106630 | 0.64 | CYP1A2 (0.48) | CYP1A2KDM4EMEN1ALDH1A1CYP3A4 | |
| SCHEMBL20793908 | 0.63 | HCAR2 (0.43) | KDM4EALDH1A1MAPTKMT2A | |
| SCHEMBL17183668 | 0.62 | HTR2B (0.61) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072687-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF GEOGRAPHIC ATROPHY | Ocuphire Pharma, Inc. (US) | 2025-04-03 | — | — | WO | disclosed |